Muñoz-Negrete F J, González-Martín-Moro J, Casas-Llera P, Urcelay-Segura J L, Rebolleda G, Ussa F, Güerri Monclús N, Méndez Hernández C, Moreno-Montañés J, Villegas Pérez M P, Pablo L E, García-Feijoó J
Servicio de Oftalmología, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá, OFTARED, Alcalá de Henares, Madrid, España.
Servicio de Oftalmología, Hospital Universitario del Henares, Universidad Francisco de Vitoria, Coslada, Madrid, España.
Arch Soc Esp Oftalmol. 2015 Mar;90(3):119-38. doi: 10.1016/j.oftal.2014.09.014. Epub 2014 Nov 15.
To present a clinical practice guideline update on the medical, laser, and surgical treatment of primary angle closure glaucoma (PACG) in adults.
Following the formulation of key questions using the PICO scheme (Patient/Problem, Intervention, Comparison, Outcome), a systematic review was performed on the literature published to date, including international clinical practice guidelines. The AMSTAR and Risk of Bias tools were used for evaluating the quality of the information. The level of evidence and grade of recommendation was established following the Scottish Intercollegiate Guidelines Network (SIGN) system.
Following the above methodology, recommendations of medical, laser and surgical treatment in adult PACG and levels of evidence are presented.
Although the level of scientific evidence for many of the questions raised is not very high, a review is presented on updated treatment recommendations for adult PACG. Among the limitations for the implementation of these recommendations is that most studies have been conducted in Asian populations, and that the effectiveness is measured almost exclusively in terms of reducing intraocular pressure, and does not include visual function, quality of life or cost-effectiveness parameters.
介绍关于成人原发性闭角型青光眼(PACG)的药物、激光和手术治疗的临床实践指南更新内容。
使用PICO方案(患者/问题、干预措施、对照、结局)制定关键问题后,对迄今为止发表的文献进行了系统综述,包括国际临床实践指南。使用AMSTAR和偏倚风险工具评估信息质量。依据苏格兰跨学院指南网络(SIGN)系统确定证据水平和推荐等级。
按照上述方法,给出了成人PACG的药物、激光和手术治疗建议及证据水平。
尽管所提出的许多问题的科学证据水平不是很高,但仍对成人PACG的最新治疗建议进行了综述。这些建议实施的局限性包括,大多数研究是在亚洲人群中进行的,并且有效性几乎仅根据降低眼压来衡量,未包括视觉功能、生活质量或成本效益参数。